A 62-year-old woman developed allergic reaction to rituximab [dosage, route, duration of treatment to reaction onset and outcome not stated]. The woman was diagnosed with a low-grade B-cell non-Hodgkin's lymphoma and was treated with rituximab and bendamustine. Subsequently, she developed an allergic reaction to rituximab. She completed five cycles of bendamustine and showed good response. …